老年人心源性休克:与年龄相关的风险及管理方法
该美国心脏协会科学声明聚焦老年心源性休克患者,指出其短期死亡率达30%至50%,且高龄与不良预后相关,但老年人常被排除在治疗分析之外。声明强调不应仅以年龄作为临床决策依据,需采用综合跨学科方法评估风险和管理。
要点
- 老年心源性休克患者短期死亡率达30%至50%。
- 不应仅以年龄作为治疗决策的唯一依据。
- 需综合跨学科方法评估风险并制定管理策略。
核心结论
- 年龄是心源性休克患者死亡的非可改变危险因素,但不应单独用于指导个体化治疗决策。
研究设计与样本
- 美国心脏协会科学声明,总结老年心源性休克的流行病学、风险评估和院内管理方法。
主要发现
- 心源性休克短期死亡率为30%至50%。
- 老年人常被排除在治疗分析之外,缺乏针对性的评估和管理策略。
- 部分项目为心脏移植和持久性左心室辅助装置等介入策略设定年龄上限。
临床怎么用
- 对老年心源性休克患者应采用综合跨学科方法进行风险评估。
- 不应仅以年龄作为选择治疗策略的排除标准。
局限性
- 老年人被排除在治疗分析之外,导致针对性策略缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking. Individual programs oftentimes develop upper age limits for various interventional strategies for their patients, including heart transplantation and durable left ventricular assist devices. However, age as a lone parameter should not be used to guide individual patient management decisions in cardiogenic shock. In the assessment of risk in older adults with cardiogenic shock, a comprehensive, interdisciplinary approach is central to developing best practices. In this American Heart Association scientific statement, we aim to summarize our contemporary understanding of the epidemiology, risk assessment, and in-hospital approach to management of cardiogenic shock, with a unique focus on older adults.
引用
- Blumer, Kanwar, Barnett, et al. Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 38406869. doi:10.1161/CIR.0000000000001214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。